文献速递消化系统肿瘤

良性胆囊疾病后的胰腺癌风险:一项瑞典人群队列研究

Pancreatic cancer risk after benign gallbladder disease: A Swedish population-based cohort study.
PubMed 文献 · Eur J Cancer · 2024-11-19

该研究基于瑞典全国登记数据,纳入1992-2016年20-79岁组织学确诊良性胆囊疾病者130907例及匹配非暴露对照571618例,随访15年。良性胆囊疾病后胰腺癌风险主要见于前2年,粗发病率为84/10万人年 vs 对照31/10万人年,HR 2.74(95%CI 2.31,3.25)。

要点

  • 良性胆囊疾病后胰腺癌风险升高主要集中在前2年,HR 2.74(95%CI 2.31,3.25)。
  • 20-49岁人群前2年胰腺癌风险升高更明显,HR 7.64(95%CI 3.73,15.65)。
  • 十二指肠癌呈相似模式,原发性肝癌风险全程升高,肝外胆管癌风险由早期升高转为降低。

核心结论

  • 良性胆囊疾病后胰腺癌风险升高主要见于前2年,作者呼吁对胆囊炎后最初几年的临床随访开展更多研究以发现早期胰腺癌。

研究设计与样本

  • 全国性登记为基础的队列研究,纳入1992-2016年瑞典20-79岁组织学确诊良性胆囊疾病(胆囊炎和/或胆囊切除术)者130907例及5倍匹配非暴露人群对照571618例。
  • 随访自良性胆囊疾病后1个月开始,采用Poisson回归和Cox回归估计15年内的发病率(IR)和风险比(HR)及95%置信区间(CI),完全调整模型包括性别、年龄、年份、教育、2型糖尿病、肥胖、吸烟相关障碍和酒精相关障碍。
  • 分析按随访时间分层,并应用灵活参数模型评估时变效应,交互模型用于识别高危患者组。

主要发现

  • 15年内良性胆囊疾病暴露组检出胰腺癌680例,非暴露组检出1890例。
  • 胰腺癌风险升高主要见于前2年:暴露组IR 84/10万人年(95%CI 73,95)vs 非暴露组31/10万人年(95%CI 27,34),HR 2.74(95%CI 2.31,3.25)。
  • 十二指肠癌呈相同模式,原发性肝癌风险全程升高,肝外胆管癌风险早期升高后随时间转为降低。
  • 20-49岁人群前2年胰腺癌风险升高更明显,HR 7.64(95%CI 3.73,15.65)。

临床怎么用

  • 作者认为研究结果呼吁对胆囊炎后最初几年的临床随访开展更多研究,以发现早期胰腺癌。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: The purpose of this nationwide registry-based cohort study was to outline pancreatic cancer risk after benign gallbladder disease (GBD). Anatomically adjacent cancers were investigated to address incidental findings. METHODS: We included all Swedes aged 20-79 years with histologically confirmed GBD (cholecystitis and/or cholecystectomy) in 1992-2016 and five matched non-exposed population comparators. Follow-up started one month after GBD and incidence rates (IR) and hazard ratios (HR) with 95 % confidence intervals (CI) up to 15 years after GBD were estimated using Poisson and Cox regression, respectively. Fully adjusted models included sex, age, year, education, type 2 diabetes, obesity, smoking-, and alcohol-related disorders. Analyses were stratified by follow-up and flexible parametric models applied to assess time-varying effects. Interaction models were used to identify patient groups at risk. RESULTS: 680 and 1890 incident pancreatic cancers were detected over 15 years in 130907 GBD exposed and 571618 non-exposed, respectively. An excess pancreatic cancer risk was mainly seen within the first 2 years; IR: 84 [95 % CI 73,95] versus 31 [95 % CI 27,34] per 100000 person-years corresponding to an HR of 2.74 [95 % CI 2.31,3.25]. The same pattern was noted for duodenal cancer while primary liver cancer risk was elevated across follow-up. An initial extrahepatic biliary cancer risk elevation shifted to a reduction over time. The 2-year pancreatic cancer risk was augmented in younger (age 20-49) individuals, HR 7.64 [95 % CI 3.73,15.65]. CONCLUSION: Our findings urge more studies on the clinical follow-up the first years after cholecystitis to detect early pancreatic cancer.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Radkiewicz C, Ludvigsson JF, Sparrelid E, et al. Pancreatic cancer risk after benign gallbladder disease: A Swedish population-based cohort study. Eur J Cancer. 2024. PMID: 39579639. doi:10.1016/j.ejca.2024.115140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。